NDT -- Table of Contents (15 Supplement 7)

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 15, Supplement 7 December 2000   [Index by Author]

       Original Articles

       SECTION I: EVALUATION, SELECTION AND PREPARATION OF THE POTENTIAL TRANSPLANT RECIPIENT

       SECTION II: EVALUATION AND SELECTION OF DONORS

       SECTION III: THE TRANSPLANT RECIPIENT FROM INITIAL TRANSPLANT HOSPITALIZATION TO 1 YEAR POST-TRANSPL

European Best Practice Guidelines for Renal Transplantation (Part 1). Produced by the EBPG Expert Group on Renal Transplantation

Find articles in this issue containing these words:
[Search ALL Issues]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Original Articles:

Alex M. Davison: Foreword
Nephrol. Dial. Transplant. 15: 1; doi:10.1093/ndt/15.suppl_7.1 [PDF] [Request Permissions]

François Berthoux: Preface
Nephrol. Dial. Transplant. 15: 2; doi:10.1093/ndt/15.suppl_7.2 [PDF] [Request Permissions]

SECTION I: EVALUATION, SELECTION AND PREPARATION OF THE POTENTIAL TRANSPLANT RECIPIENT:

: I.1 Epidemiological data concerning end-stage renal failure (ESRF) and its treatment in Europe
Nephrol. Dial. Transplant. 15: 3; doi:10.1093/ndt/15.suppl_7.3 [PDF] [Request Permissions]

: I.2 General evaluation
Nephrol. Dial. Transplant. 15: 4-5; doi:10.1093/ndt/15.suppl_7.4 [PDF] [Request Permissions]

: I.3 Information for the transplant recipient
Nephrol. Dial. Transplant. 15: 5; doi:10.1093/ndt/15.suppl_7.5 [PDF] [Request Permissions]

: I.4 Contra-indications for transplantation
Nephrol. Dial. Transplant. 15: 5-6; doi:10.1093/ndt/15.suppl_7.5-a [PDF] [Request Permissions]

: I.5 Risk factors/relative contra-indications
Nephrol. Dial. Transplant. 15: 6; doi:10.1093/ndt/15.suppl_7.6 [PDF] [Request Permissions]

: I.5.1 Work-up for cancer and waiting time for pre-existing cancer
Nephrol. Dial. Transplant. 15: 6. [Request Permissions]

: I.5.2 Infectious risk
Nephrol. Dial. Transplant. 15: 7-10. [Request Permissions]

: I.5.3 Recurrence of original renal disease
Nephrol. Dial. Transplant. 15: 11-19. [Request Permissions]

: I.5.4 Work-up and preventive measures for thrombotic complications
Nephrol. Dial. Transplant. 15: 20. [Request Permissions]

: I.5.5 Co-morbid conditions
Nephrol. Dial. Transplant. 15: 21-23. [Request Permissions]

: I.5.6 Individual risk factors
Nephrol. Dial. Transplant. 15: 24. [Request Permissions]

: I.6 Immunogenetic work-up of the recipient (and donor)
Nephrol. Dial. Transplant. 15: 25; doi:10.1093/ndt/15.suppl_7.25 [PDF] [Request Permissions]

: I.6.1 ABO blood grouping and HLA typing
Nephrol. Dial. Transplant. 15: 25-27. [Request Permissions]

: I.6.2 Antibody screening to evaluate sensitization status
Nephrol. Dial. Transplant. 15: 28-29. [Request Permissions]

: I.7 Pre-emptive transplantation
Nephrol. Dial. Transplant. 15: 30-31; doi:10.1093/ndt/15.suppl_7.30 [PDF] [Request Permissions]

: I.8 Waiting list
Nephrol. Dial. Transplant. 15: 31; doi:10.1093/ndt/15.suppl_7.31 [PDF] [Request Permissions]

: I.8.1 Assignment to the transplant waiting list
Nephrol. Dial. Transplant. 15: 31. [Request Permissions]

: I.8.2 Regular check-up while on waiting list
Nephrol. Dial. Transplant. 15: 31. [Request Permissions]

: I.8.3 Principals of organ sharing
Nephrol. Dial. Transplant. 15: 31-32. [Request Permissions]

: I.9 Pre-operative transfusion
Nephrol. Dial. Transplant. 15: 33-35; doi:10.1093/ndt/15.suppl_7.33 [PDF] [Request Permissions]

: I.10 Specific groups
Nephrol. Dial. Transplant. 15: 35; doi:10.1093/ndt/15.suppl_7.35 [PDF] [Request Permissions]

: I.10.1 Simultaneous transplantation of kidney and pancreas
Nephrol. Dial. Transplant. 15: 35. [Request Permissions]

: I.10.2 Combined transplants with liver, heart and lung
Nephrol. Dial. Transplant. 15: 36. [Request Permissions]

: I.10.3 Retransplants
Nephrol. Dial. Transplant. 15: 37-38. [Request Permissions]

SECTION II: EVALUATION AND SELECTION OF DONORS:

: II.1 Cadaveric heart-beating donors
Nephrol. Dial. Transplant. 15: 39; doi:10.1093/ndt/15.suppl_7.39 [PDF] [Request Permissions]

: II.1.1 Selection of donors
Nephrol. Dial. Transplant. 15: 39-42. [Request Permissions]

: II.1.2 Determination of brain death
Nephrol. Dial. Transplant. 15: 43. [Request Permissions]

: II.1.3 Support of the potential donor and optimization of organ function
Nephrol. Dial. Transplant. 15: 44-45. [Request Permissions]

: II.2 Cadaveric non-heart beating donors
Nephrol. Dial. Transplant. 15: 46-47; doi:10.1093/ndt/15.suppl_7.46 [PDF] [Request Permissions]

: II.3 Living kidney donors
Nephrol. Dial. Transplant. 15: 47; doi:10.1093/ndt/15.suppl_7.47 [PDF] [Request Permissions]

: II.3.1 Related living kidney donors
Nephrol. Dial. Transplant. 15: 48-49. [Request Permissions]

: II.3.2 Unrelated living kidney donors
Nephrol. Dial. Transplant. 15: 50. [Request Permissions]

: II.4 Immunogenetic work-up of the donor
Nephrol. Dial. Transplant. 15: 51; doi:10.1093/ndt/15.suppl_7.51 [PDF] [Request Permissions]

SECTION III: THE TRANSPLANT RECIPIENT FROM INITIAL TRANSPLANT HOSPITALIZATION TO 1 YEAR POST-TRANSPL:

: III.1 Cross-matching donor/recipient
Nephrol. Dial. Transplant. 15: 52; doi:10.1093/ndt/15.suppl_7.52 [PDF] [Request Permissions]

: III.1.1 ABO blood group matching
Nephrol. Dial. Transplant. 15: 52-53. [Request Permissions]

: III.1.2 HLA matching and mismatching
Nephrol. Dial. Transplant. 15: 54-55. [Request Permissions]

: III.1.3 Pre-transplant antibody cross-matching
Nephrol. Dial. Transplant. 15: 56-57. [Request Permissions]

: III.1.4 Post-transplant antibody monitoring
Nephrol. Dial. Transplant. 15: 58. [Request Permissions]

: III.2 Pre-transplant dialysis/volume correction
Nephrol. Dial. Transplant. 15: 59-60; doi:10.1093/ndt/15.suppl_7.59 [PDF] [Request Permissions]

: III.3 Prophylactic immunosuppression with biological agents (also called induction therapy)
Nephrol. Dial. Transplant. 15: 60-63; doi:10.1093/ndt/15.suppl_7.60 [PDF] [Request Permissions]

: III.4 Initial and maintenance immunosuppressive treatment
Nephrol. Dial. Transplant. 15: 63-67; doi:10.1093/ndt/15.suppl_7.63 [PDF] [Request Permissions]

: III.5 Evaluation of renal transplant patients and their grafts in the first post-transplant year
Nephrol. Dial. Transplant. 15: 67-69; doi:10.1093/ndt/15.suppl_7.67 [PDF] [Request Permissions]

: III.6 Evaluation of patients with delayed graft function
Nephrol. Dial. Transplant. 15: 69-70; doi:10.1093/ndt/15.suppl_7.69 [PDF] [Request Permissions]

: III.7 Evaluation of the patient with fever
Nephrol. Dial. Transplant. 15: 70-71; doi:10.1093/ndt/15.suppl_7.70 [PDF] [Request Permissions]

: III.8 Infectious complications
Nephrol. Dial. Transplant. 15: 71; doi:10.1093/ndt/15.suppl_7.71 [PDF] [Request Permissions]

: III.8.1 Cytomegalovirus (CMV) infection
Nephrol. Dial. Transplant. 15: 71-74. [Request Permissions]

: III.8.2 Hepatitis B virus infection
Nephrol. Dial. Transplant. 15: 75. [Request Permissions]

: III.8.3 Hepatitis C virus infection
Nephrol. Dial. Transplant. 15: 76. [Request Permissions]

: III.9 Rejection: Diagnosis and treatment
Nephrol. Dial. Transplant. 15: 77; doi:10.1093/ndt/15.suppl_7.77 [PDF] [Request Permissions]

: III.9.1 Clinical and pathological diagnosis of acute rejection
Nephrol. Dial. Transplant. 15: 77-79. [Request Permissions]

: III.9.2 Treatment of acute rejection episodes
Nephrol. Dial. Transplant. 15: 80-82. [Request Permissions]

: III.10 Standards of graft and patient survival
Nephrol. Dial. Transplant. 15: 83-85; doi:10.1093/ndt/15.suppl_7.83 [PDF] [Request Permissions]

Nephrology Dialysis Transplantation

Original Articles:

SECTION I: EVALUATION, SELECTION AND PREPARATION OF THE POTENTIAL TRANSPLANT RECIPIENT:

SECTION II: EVALUATION AND SELECTION OF DONORS:

SECTION III: THE TRANSPLANT RECIPIENT FROM INITIAL TRANSPLANT HOSPITALIZATION TO 1 YEAR POST-TRANSPL: